Home LiteratureArticle Details
PMID: 9802888 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.

The Journal of clinical investigation ·Vol. 102 ·No. 9 ·1998-11-01 ·Pages 1742-8

Murphy WJ, Welniak LA, Taub DD, Wiltrout RH, Taylor PA, Vallera DA, Kopf M, Young H, Longo DL, Blazar BR

Abstract

Graft-versus-host disease (GVHD), in which immunocompetent donor cells attack the host, remains a major cause of morbidity after allogeneic bone marrow transplantation (BMT). To understand the role of cytokines in the pathobiology of GVHD, we used cytokine knockout (KO) mice as a source of donor T cells. Two different MHC-disparate strain combinations were examined: BALB/c (H2(d)) donors into lethally irradiated C57BL/6 (H2(b)) recipients or C57BL/6 (H2(b)) donors into B10.BR (H2(k)) recipients. Donor cells were from mice in which either the interferon-gamma (IFN-gamma) or the IL-4 gene was selectively disrupted to understand the role of these cytokines in acute GVHD. In both strain combinations the same pattern was noted with regard to GVHD onset and morbidity. All mice exhibited the classic signs of acute GVHD: weight loss with skin, gut, and liver pathology resulting in morbidity and mortality. Surprisingly, donor cells obtained from mice lacking IFN-gamma gave rise to accelerated morbidity from GVHD when compared with cells from wild-type control donors. Similar results were obtained using normal donors when neutralizing antibodies to IFN-gamma were administered immediately after the BMT. These results suggest that IFN-gamma plays a role in protection from acute GVHD. In marked contrast, cells obtained from IL-4 KO mice resulted in protection from GVHD compared with control donors. Splenocytes from IFN KO mice stimulated with a mitogen proliferated to a significantly greater extent and produced more IL-2 compared with splenocytes obtained from IL-4 KO or control mice. Additionally, there was increased IL-2 production in the spleens of mice undergoing GVHD using IFN-gamma KO donors. These results therefore indicate, with regard to the TH1/ TH2 cytokine paradigm, the absence of a TH1-type cytokine can be deleterious in acute GVHD, whereas absence of a TH2 cytokine can be protective.

MeSH Terms
Animals Bone Marrow Transplantation/immunology Cell Division Concanavalin A/pharmacology Graft vs Host Disease/immunology Interferon-gamma/immunology Interleukin-2/biosynthesis Interleukin-4/immunology Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Knockout Mitogens/pharmacology Spleen/cytology Transplantation, Homologous
Chemicals
Interleukin-2 Mitogens Concanavalin A Interleukin-4 Interferon-gamma
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Murphy W J
SAIC-Frederick, Division of Basic Science, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702, USA. murphyw@mail.ncifcrf.gov
Welniak L A
Taub D D
Wiltrout R H
Taylor P A
Vallera D A
Kopf M
Young H
Longo D L
Blazar B R
References (32)
32 references, click to expand
  1. Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease.
    Transplantation. 1996 Nov 15;62(9):1278-85 PMID: 8932272
  2. The Th1/Th2 paradigm and the allograft response.
    Curr Opin Immunol. 1996 Oct;8(5):688-93 PMID: 8902395
  3. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
    J Immunol. 1997 Aug 1;159(3):1208-15 PMID: 9233615
  4. The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation.
    Immunol Rev. 1997 Jun;157:167-76 PMID: 9255629
  5. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.
    Blood. 1997 Oct 15;90(8):3204-13 PMID: 9376604
  6. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.
    J Clin Invest. 1997 Nov 15;100(10):2449-56 PMID: 9366559
  7. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.
    J Exp Med. 1998 Feb 16;187(4):537-46 PMID: 9463404
  8. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    J Immunol. 1998 Jul 15;161(2):631-40 PMID: 9670937
  9. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma.
    J Immunol. 1988 Mar 1;140(5):1506-10 PMID: 3126227
  10. Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.
    Proc Natl Acad Sci U S A. 1990 Aug;87(15):5633-7 PMID: 2377601
  11. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
    Science. 1993 Mar 19;259(5102):1739-42 PMID: 8456300
  12. Disruption of the murine IL-4 gene blocks Th2 cytokine responses.
    Nature. 1993 Mar 18;362(6417):245-8 PMID: 8384701
  13. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    J Immunol. 1993 Dec 1;151(11):6451-9 PMID: 8245478
  14. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.
    J Immunol. 1994 Feb 1;152(3):1004-13 PMID: 7905495
  15. Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens.
    Transplantation. 1994 Dec 15;58(11):1251-7 PMID: 7992370
  16. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts.
    Blood. 1995 Feb 1;85(3):842-51 PMID: 7833486
  17. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    J Immunol. 1995 Mar 15;154(6):2687-96 PMID: 7876541
  18. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
    Blood. 1995 May 1;85(9):2607-18 PMID: 7537122
  19. IL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation.
    Bone Marrow Transplant. 1995 Mar;15(3):395-9 PMID: 7599564
  20. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
    J Immunol. 1995 Jul 15;155(2):585-93 PMID: 7608537
  21. The regulation of immunity to Leishmania major.
    Annu Rev Immunol. 1995;13:151-77 PMID: 7612219
  22. Interleukin-12 inhibits murine graft-versus-host disease.
    Blood. 1995 Sep 15;86(6):2429-38 PMID: 7662991
  23. Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease.
    Bone Marrow Transplant. 1995 May;15(5):727-32 PMID: 7670402
  24. Bone marrow transplantation.
    Transplant Proc. 1995 Oct;27(5):2649-52 PMID: 7482865
  25. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).
    J Immunol. 1996 Jan 1;156(1):5-7 PMID: 8598493
  26. Dysregulation of cytokines during graft-versus-host disease.
    J Hematother. 1996 Feb;5(1):3-14 PMID: 8646479
  27. Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease.
    Blood. 1996 Aug 1;88(3):1113-21 PMID: 8704222
  28. The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency.
    Transplantation. 1994 Jan;57(2):273-9 PMID: 8310520
  29. Graft-versus-host disease and the Th1/Th2 paradigm.
    Immunol Res. 1996;15(1):50-73 PMID: 8739565
  30. Accelerated clearance of Onchocerca microfilariae and resistance to reinfection in interleukin-4 gene knockout mice.
    Parasite Immunol. 1995 Dec;17(12):653-7 PMID: 8834765
  31. The immunopathophysiology of acute graft-versus-host-disease.
    Stem Cells. 1996 Sep;14(5):473-89 PMID: 8888489
  32. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
    Bone Marrow Transplant. 1997 Mar;19(6):601-6 PMID: 9085739
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1998-11-01
Pages
1742-8
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC509122
Subset
IM
Grants
NCI NIH HHS · N01-CO-5600 · United States
NIAID NIH HHS · R01 AI34495-05 · United States
NHLBI NIH HHS · R01 HL56067 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com